The reaction steps responsible for the highly enantioselective
asymmetric copolymerization of propene
with carbon monoxide catalyzed by a cationic Pd(II) complex
bearing an unsymmetrical chiral bidentate phosphine−phosphite, (R,S)-BINAPHOS
[(R,S)-2-(diphenylphosphino)-1,1‘-binaphthalen-2‘-yl
1,1‘-binaphthalene-2,2‘-diyl phosphite = L1], have been studied. Stepwise
identification and characterization were carried out for catalyst
precursors
(SP-4-2)- and
(SP-4-3)-Pd(CH3)Cl(L1)
(1a and 1b) and
(SP-4-3)-[Pd(CH3)(CH3CN)(L1)]·X1
(X1 = B{3,5-(CF3)2C6H3}4)
(2), and complexes related to the reaction steps,
(SP-4-3)-[Pd(COCH3)(CH3CN)(L1)]·X1
(3), (SP-4-3)- and
(SP-4-4)-[Pd{CH2CH(CH3)COCH3}(L1)]·X1
(4a and 4b),
(SP-4-3)-[Pd{COCH2CH(CH3)COCH3}(CH3CN)(L1)]·X1 (5), and
(SP-4-3)-[Pd{CH2CH(CH3)COCH2CH(CH3)COCH3}(L1)]·X1
(6). An X-ray structure of alkyl
complex 4a has been obtained. Studies on
[Pt(CH3)2(L1)]
(8) reveal that the methyl group is more stabilized at
a
position trans to the phosphine than at the cis
position. This is consistent with the structures of
1−6 in which all
carbon substituents are trans to the phosphine moiety in
their major forms. On the basis of analogous studies
using
platinum complexes, an isomerization from
(SP-4-3)-[Pd(CH3)(CO)(L1)]·X1
(13a) to the (SP-4-4) isomer (13b)
is
suggested to occur for the CO-insertion process 2 →
3, which results in the activation of the methyl group for
the
migration to the coordinated CO. Rapid equilibrium was observed
between the two isomers 4a and 4b during
the
CO insertion process to give 5. Theoretical studies
have been carried out on the transformation of 3 to
4a and 4b.
The B3LYP and MPn calculations indicated that the alkene insertion
into the Pd−acyl bond trans to a phosphine is
more favorable than that into the Pd−acyl bond trans to a
phosphite. The MM3 calculations demonstrated that one
specific transition structure is more favorable than the other possible
transition structures for the transformation of
(SP-4-4)-[Pd(COCH3)(propene)(L1)]·X1
(14b) to 4b. The difference originates from
the steric effects of the
BINAPHOS ligand, and the results account for high enantio- and
regioselectivities experimentally observed. The
two key steps, propene insertion into 3 and CO insertion
into 4, were monitored by 1H NMR spectroscopy.
The
activation energies for these two steps were estimated to be
19.0−19.6 kcal/mol at −20 to 0 °C, their difference
being insignificant. The living nature of the copolymerization was
proved. Some related chiral ligands were examined
for the copolymerization. Copolymerization of other olefins with
CO was also investigated.
Treatment of [RuCl 2 (COD)] n with (R)-p-MeO-BINAP (p-MeO-BINAP ) 2,2′-bis(bis(p-methoxyphenyl)phosphino)-1,1′-binaphthyl) in toluene in the presence of triethylamine afforded the anionic dinuclear complex [NH 2 Et 2 ][{RuCl((R)-p-MeO-BINAP)} 2 (µ-Cl) 3 ] ((R)-2), whose structure has been determined by an X-ray crystallographic study. Complex 2 is an efficient catalyst for asymmetric hydrogenation of functionalized olefins and ketones.Recently, a number of monomeric BINAP-Ru(II) complexes (BINAP ) 2,2′-bis(diphenylphosphino)-1,1′binaphthyl) have been prepared and are effective catalysts for the asymmetric hydrogenations of a variety of olefins and ketones. [1][2][3][4][5][6][7][8][9][10][11] Although the BINAP-Ru complexes bearing halogen ligands are highly active catalysts, little information about their structure in organic solvents has been obtained. 12 A dinuclear complex formulated as Ru 2 Cl 4 (BINAP) 2 ‚NEt 3 (1), which is the first reported dinuclear BINAP-Ru(II) complex, was isolated by Ikariya et al., 13 but its structure has not been elucidated. Herein we report the first X-ray
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.